Exploring the Mechanism of Huachansu Injection for Lung Cancer Based on Network Pharmacology and Molecular Docking
The study provides significant theoretical support for understanding the pharmacological basis and mechanisms of HCSI in the treatment of NSCLC, and lays the foundation for developing new multitargeted treatment strategies for NSCLC based on HCSI.
Authors
- Yuanlei Yue (ORCID: https://orcid.org/0000-0002-0552-2911)
- Chun-Qin Zhao
- Qi Song (ORCID: https://orcid.org/0000-0003-4173-3828)
- Chunling Qin
- Mingyu Liu (ORCID: https://orcid.org/0000-0003-0940-8953)
- Xiao Li (ORCID: https://orcid.org/0000-0002-6120-3800)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-11-22
- DOI
- https://doi.org/10.2174/0113816128404080251014113948
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00